British Generic Manufacturers Association (BGMA)

"Weight loss medicines could prove to be a key tool in getting Britain fighting fit economically."   In a new article for Health Service Journal, our Chief Executive Mark Samuels explores how competing off-patent versions of weight loss medicines will bring greater capacity and choice, allowing the NHS to start treating increased numbers of patients with the broader long-term benefits that can deliver. However, these medicines should not be seen as a panacea for the obesity crisis. If used effectively, they can make a significant difference, but as an association, we believe certain safeguards must be in place.   Read the article: https://lnkd.in/ebb5H2-C   #WeightLoss #HealthPolicy #Economy

Accord UK’s Country Manager, Generics, Clara Carter, recently addressed the pressing challenges faced by community pharmacies during the "Generics, Branded Generics, and Biosimilars: NHS Update" panel discussion hosted by the Life Science Access Academy. In this article, Clara delves into how community pharmacies are navigating a perfect storm of issues—including an increasingly complex supply chain, funding shortfalls, and a rise in pharmacy closures. With multiple stakeholders across the supply chain, any disruption has a ripple effect, leaving pharmacies struggling to access the medicines they need. Clara also discusses the Our Future Health initiative and how its findings could reshape the future demands on pharmacies, offering practical suggestions on how we can support these essential services as they navigate upcoming changes. Read Clara’s full article to explore these key issues and the future of community pharmacies. (S)

Our chief executive Mark Samuels was on BBC radio 4’s Today Programme this morning discussing #ADHD shortages. He talked about the issues causing delays and the importance of finding solutions and how manufacturers are tirelessly working to increase supply. New competitors are expected to start supplying very soon, increasing the resilience of these critical medicines. Listen from 02:35:00: https://lnkd.in/eqvV5v98

Please welcome Clara Carter as the first Chair of our new Women’s Networking Group! Clara brings her experience as the UK Country Manager, Generics for Accord Healthcare. On her appointment, Clara says: “At its heart, I want the group to be about identifying and nurturing talent and breeding confidence in future industry leaders.” The new group aims to create learning and networking opportunities for women in the generic and biosimilar industry. Find out more about our initiative and her role: https://lnkd.in/eKAhJH6q

#GlobalBiosimilarsWeek is here! Each day, #biosimilars provide essential care for millions of people around the globe. In order to provide more patients with care, we need policies that support greater access to biosimilar medicines. Join us in supporting these life-changing medicines: https://lnkd.in/d_cpUnQ

We’re thrilled to announce that we’re a winner at the Association Excellence Awards 2024!   Congratulations to our Chief Executive Mark Samuels for winning the Association Leadership Award (up to 2000 members) for his outstanding contribution to the generic medicine sector. #AssociationExcellence #AEA24

Generic medicine manufacturers make up 80% of the largest suppliers to the NHS by volume. Government support for the off-patent sector ensures patients continue to receive the vital prescription drugs that they need. Learn more about generic medicine in our factsheet: https://bit.ly/3N2PENG #DrugShortages #Medicines #HealthPolicy

We were delighted to have participated in Public Policy Projects' #IntegratedCareDeliveryForum2024 in London.   Our CEO Mark Samuels took part on the panel "Mitigating the impact of medicines shortages" to discuss the role of generic medicine in widening access to treatments. Learn more about generic medicine: https://bit.ly/3N2PENG

Great to see Rt Hon Rachel Reeves and Peter Kyle at Accord Healthcare's Newcastle plant to mark a £50m investment in generic medicines manufacturing in the UK. Generic medicines account for 4 in 5 NHS prescriptions or 2.4 million packs of medicines dispensed each day by pharmacies. The Government's new Life Sciences Innovative Manufacturing Fund will support UK growth, jobs and the country's medicine supply resilience.